Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Hemangiosarcoma is a common neoplasm of the spleen in older dogs. However, diagnosis is complicated by necrosis and hemorrhage, which can mimic a number of benign processes. Currently, there is no consensus about the number of sections pathologists should examine to rule out hemangiosarcoma. To...

Author(s)
Herman, E. J.; Stern, A. W.; Fox, R. J.; Dark, M. J.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Veterinary Pathology, 2019, 56, 6, pp 856-859
Abstract

Hemangiosarcoma is a type of malignant vascular tumour that commonly affects the canines and has a very poor prognosis. Five dogs affected with cutaneous hemangiosarcoma were presented to Referral Veterinary Polyclinic, Indian Veterinary Research Institute, Izatnagar, over a 6-month period. All of...

Author(s)
Khan Sharun; Basha, M. A.; Shah, M. A.; Kumar, K.; Pawan Kumar; Shivaraju, S.; Pawde, A. M.; Amarpal, K.
Publisher
Springer Science + Business Media, London, UK
Citation
Comparative Clinical Pathology, 2019, 28, 6, pp 1815-1822
Abstract

Background: Tumors of the perianal area occur frequently in dogs, and the two most common tumors are perianal gland adenoma and anal sac adenocarcinoma; others such as mast cell tumor, lymphoma and melanoma can also occur at this site. Diagnostic cytology is a useful technique and is usually used...

Author(s)
Choi EunWha
Publisher
BioMed Central Ltd, London, UK
Citation
BMC Veterinary Research, 2019, 15, 115, pp (15 April 2019)
Abstract

Treatment options for dogs with metastatic (stage III) splenic hemangiosarcoma are limited. A doxorubicin-based chemotherapy regimen is commonly administered; however, there are no published data to support this practice. The aim of this study was to investigate the impact of maximum-tolerated-dose ...

Author(s)
Marconato, L.; Chalfon, C.; Finotello, R.; Polton, G.; Vasconi, M. E.; Annoni, M.; Stefanello, D.; Mesto, P.; Capitani, O.; Agnoli, C.; Amati, M.; Sabattini, S.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2019, 17, 4, pp 537-544
Abstract

Canine hemangiosarcoma (HSA) is an aggressive malignant endothelial tumor in dogs and characterized by poor prognosis because of its high invasiveness, high metastatic potential, and poor responsiveness to anti-cancer drugs. Although doxorubicin-based chemotherapy is regularly conducted after...

Author(s)
Morita, A.; Aoshima, K.; Gulay, K. C. M.; Onishi, S.; Shibata, Y.; Yasui, H.; Kobayashi, A.; Kimura, T.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Research in Veterinary Science, 2019, 127, pp 1-10
Abstract

In veterinary medicine, abdominal ultrasonography is used to rank the differential diagnosis of renal lesions. However, a conventional sonographic examination may show nonspecific findings. The purpose of this study was to assess the computed tomography (CT) findings of canine renal tumors,...

Author(s)
Tanaka, T.; Akiyoshi, H.; Nishida, H.; Mie, K.; Lin LeeShuan; Iimori, Y.; Okamoto, M.
Publisher
Public Library of Sciences (PLoS), San Francisco, USA
Citation
PLoS ONE, 2019, 14, 11, pp e0225211
Abstract

Background: Skeletal muscle metastases (SMMs) have been described sporadically in canine oncology. Hypothesis/Objectives: To determine the prevalence, localization, and clinical signs of SMMs associated with hemangiosarcoma (HSA) in a population of dogs presented for whole body computed tomography...

Author(s)
Carloni, A.; Terragni, R.; Morselli-Labate, A. M.; Paninarova, M.; Graham, J.; Valenti, P.; Alberti, M.; Albarello, G.; Millanta, F.; Vignoli, M.
Publisher
Wiley, Boston, USA
Citation
Journal of Veterinary Internal Medicine, 2019, 33, 2, pp 812-819
Abstract

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is an apoptosis-inducing cytokine that shows potential therapeutic value for human neoplasms, and is effective in some canine tumours; however, its potential for killing canine hemangiosarcoma (HSA) cells is unknown. Thus, we...

Author(s)
Goto, M.; Owaki, K.; Hirata, A.; Yanai, T.; Sakai, H.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2019, 17, 3, pp 285-297
AbstractFull Text

Splenic tumoral pathology in dogs has a high prevalence and is often diagnosed late. For the present study we reviewed records of canine patients submitted to the Pathology department between April 2007 and June 2018. Gross inspection and histological analyses were performed. According to our...

Author(s)
Biriș, A.; Marian, B.; Toma, C.; Negru, M.; Cătoi, C.
Publisher
Facultatea de Medicină Veterinară, Timișoara, Romania
Citation
Lucrari Stiintifice - Universitatea de Stiinte Agricole a Banatului Timisoara, Medicina Veterinara, 2019, 52, 1, pp 14-20
AbstractFull Text

Canine Hemangiosarcoma is a malignant neoplasm of blood vessel endothelial cells, highly metastatic when in its visceral form, and may also manifest as a primary cutaneous form. The canine species is described as being the most affected. Males aged between 10 and 12 years are more predisposed to...

Author(s)
Freitas, J.; Yi LinChieh; Forlani, G. S.
Publisher
Pubvet, Maringá, Brazil
Citation
PUBVET, 2019, 13, 8,

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics

Datasheet Filter

Datasheet Type